Catheterisation using lignocaine gel

The use of gel containing 2% lignocaine for catheterisation aims to make catheterisation for both males and females as pain-free as possible.

The rationale for the use of 2% lignocaine gel for catheterisation is not well-founded.

It is important to follow the UKCC (1992) guidelines on the administration of medicines, and local policy.

Nursing assessment prior to administration should identify patients at increased risk of the systemic effects of lignocaine. These include liver disease, epilepsy, hypotension, cardiac problems, pregnancy and the debilitated or frail patient. The dosage (amount) used should be reduced in the elderly and in children.

Lignocaine gel in general is safe when used topically and is unlikely to cause side-effects.

Have your say

You must sign in to make a comment.